Evolution of the Average Target: Palisade Bio, Inc.

Evolution of the Average Target - Palisade Bio, Inc.

Evolution of the Target Price: Palisade Bio, Inc.

Evolution of the Target Price - Palisade Bio, Inc.

Changes in Analyst Recommendations: Palisade Bio, Inc.

4f8796.xWW7JfFqe_DF3dRP1dRDZNZx5svIa2pDBJ5xxnsut8w.8VPJTKAYTarxnqQd-L0nJaIFg4enCA8IcMEAsw9s7_qHXN5qxAcWh5Ka7A~9a87c10f451fc45b0536ff2891bad222

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+744.83%
+42.48%
+24.46%
+8.41%
+15.87%
+17.86%
+35.3%
+1.94%
+41.27%
+72.28%
Average +100.47%
Weighted average by Cap. +27.38%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
1.160USD
Average target price
9.800USD
Spread / Average Target
+744.83%
High Price Target
25.00USD
Spread / Highest target
+2,055.17%
Low Price Target
5.000USD
Spread / Lowest Target
+331.03%

Analyst Consensus Detail

Analyst consensus - Palisade Bio, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Palisade Bio, Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Palisade Bio, Inc.
  1. Stock Market
  2. Stocks
  3. PALI Stock
  4. Consensus Palisade Bio, Inc.